title: [Diabetic cardiopathy. Pathophysiologic concepts and therapeutic approaches].
abstract: Epidemiological data reviewed suggest that diabetes itself increases the cardiac risk of diabetics (types I and II), independently from the development of coronary heart disease and in addition to other risk factors (hypertension, hypercholesterolemia, hypertriglyceridemia, smoking and others), presumably by a specific myocardial disease called "diabetic cardiopathy", or according to the recommendations of the WHO, "diabetic heart muscle disease." Disturbances of the left and right ventricular function as well as the autonomic function of the heart can be understood as signs of this specific cardiopathy. The pathophysiological mechanisms underlying this disease are not yet fully known; however, recent evidence is presented that diabetes leads to a facet of metabolic dysfunctions regarding glucose and energy metabolism, calcium homeostasis and the expression of specific proteins that diminish the ability of the heart to respond to increased workload and increase the vulnerability of the heart in diabetes. Since preliminary experimental data indicate that inhibitors of the angiotensin-converting enzyme can protect the heart in diabetes, it is intriguing to suggest that increased release of angiotensin II plays a significant role in the change from reduced adaptability to irreversible damage of the heart in diabetes.
authors.affiliation: Diabetes-Forschungsinstitut, Düsseldorf.
authors.forename: P
authors.initials: P
authors.lastname: Rösen
authors.forename: G
authors.initials: G
authors.lastname: Pogatsa
authors.forename: D
authors.initials: D
authors.lastname: Tschöpe
authors.forename: K
authors.initials: K
authors.lastname: Addicks
authors.forename: H
authors.initials: H
authors.lastname: Reinauer
mesh_terms: D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D001342:Autonomic Nervous System Diseases / Q000188:drug therapy / Q000503:physiopathology; D009202:Cardiomyopathies / Q000188:drug therapy / Q000503:physiopathology*; D003131:Combined Modality Therapy; D003920:Diabetes Mellitus / Q000188:drug therapy / Q000503:physiopathology*; D006333:Heart Failure / Q000188:drug therapy / Q000503:physiopathology; D006439:Hemodynamics / Q000187:drug effects / Q000502:physiology*; D006801:Humans; D009206:Myocardium / Q000378:metabolism
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors
vernacular_title: Diabetische Kardiopathie. Pathophysiologische Konzepte und therapeutische Ansätze.